Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience.
about
3D conformal hypofractionated radical radiotherapy in early glottic cancerFunctional organ preservation in laryngeal and hypopharyngeal cancer.Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.Carotid dosimetry for T1 glottic cancer radiotherapy.Transoral laser surgery versus radiotherapy for tumour stage 1a or 1b glottic squamous cell carcinoma: systematic review of local control outcomes.Impact of geometric variations on delivered dose in highly focused single vocal cord IMRT.An individualised treatment algorithm for tumour stage 1 glottic squamous cell carcinoma.Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions.Short treatment time and excellent treatment outcome in accelerated hyperfractionated radiotherapy for T1 glottic cancerSame strategy for pitfalls of radiotherapy in different anatomical districts.Laryngeal cancer: United Kingdom National Multidisciplinary guidelines.SBRT for early-stage glottic larynx cancer-Initial clinical outcomes from a phase I clinical trial.Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experienceHypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival.Comparison between 4-MV and 6-MV radiotherapy in T1N0 glottic cancer.Differences in survival outcome between stage I and stage II glottic cancer: A SEER-based analysis.Evaluation of acute/late toxicity and local recurrence in T1-T2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT).Hypofractionated accelerated radiotherapy in T1-3 N0 cancer of the larynx: A prospective cohort study with historical controls.Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.Early glottic cancer: role of MRI in the preoperative staging.Use of multiple biological markers in radiotherapy-treated head and neck cancer.Conventional fractionation should not be the standard of care for T2 glottic cancer.Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy.Definitive radiotherapy for T1 glottic squamous cell carcinoma: a 15-year Cruces University Hospital experience.Online dosimetric evaluation of larynx SBRT: A pilot study to assess the necessity of adaptive replanning.
P2860
Q27012727-B60BF99C-29CE-468F-AA89-64D018CA4601Q30467853-3BF058BC-91AA-4AB0-9330-9C23D473FAC8Q33431325-7AF28B5A-6548-4E0F-85C2-9B9B99989AC1Q33823152-CF4A2CF3-882A-402A-AF44-9F56AB96E682Q34802911-38898038-9B96-418C-8496-CE27828A946DQ34860152-55C6BF56-6AA8-41E6-9AF3-635DD9390198Q35019132-87761224-019C-40FC-96F6-3063F22015F1Q35071640-D293C453-8FCF-45B5-8DC5-B453B8AEDA96Q35784258-3AAE8BB4-AE7D-495A-9D80-882CDD194BFDQ35867983-C9EF8833-58CC-4386-A9C0-D763B7BC9C1EQ35900553-2ED67832-2CF2-4876-B4B7-74119D371D7BQ36191405-5D2C6D3D-8414-47C5-A322-D65CB93EF4F2Q36295218-7496F7DE-F3F0-49E3-8B97-54CF39500267Q36484021-A7930AC7-24A0-495E-8C08-D3354AD9D060Q38776762-86F40DC1-BE9C-4275-8564-A2C041C2C894Q38847346-D8A5D07E-29ED-4E75-BB7F-560A57AF7AD9Q40799747-CD1EDE6D-4539-4208-8530-544420776F90Q42001440-F8388099-5B83-4F8D-A31F-6789A6AB0880Q42591198-C42A5F55-8666-4676-897F-D0FDECFB19ADQ42691772-F4EF34FE-A085-4D45-A57F-262967897756Q42853481-6BD9AC47-5223-4EDF-9A49-E0DD8C5516FFQ43101270-FF5EB935-35B6-4383-B49C-D05FA86E321BQ43726687-095188D3-6A1B-4C19-A3F0-9D9D016BD799Q43756484-57FF539E-C5AA-48CE-A83F-A3F046ECC16DQ50864563-EAE176DB-D608-46B6-BFDF-97F6916BE800Q55455714-3CECAC33-E820-4985-9155-B026A470A7BB
P2860
Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Three weeks radiotherapy for T ...... l Marsden Hospital Experience.
@ast
Three weeks radiotherapy for T ...... l Marsden Hospital Experience.
@en
type
label
Three weeks radiotherapy for T ...... l Marsden Hospital Experience.
@ast
Three weeks radiotherapy for T ...... l Marsden Hospital Experience.
@en
prefLabel
Three weeks radiotherapy for T ...... l Marsden Hospital Experience.
@ast
Three weeks radiotherapy for T ...... l Marsden Hospital Experience.
@en
P2093
P1476
Three weeks radiotherapy for T ...... l Marsden Hospital Experience.
@en
P2093
Andrew J Sykes
J Michael Henk
Kathleen L Mais
Nicholas J Slevin
Raghavendra V Gowda
Ric Swindell
P304
P356
10.1016/S0167-8140(03)00059-8
P577
2003-08-01T00:00:00Z